Savara, Inc. (SVRA)
4.81
-0.24
(-4.66%)
USD |
NASDAQ |
Oct 02, 16:00
4.815
0.00 (0.00%)
After-Hours: 20:00
Savara Max Drawdown (5Y) : 93.79% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 93.79% |
| August 31, 2026 | 96.98% |
| July 31, 2026 | 97.41% |
| June 30, 2026 | 97.41% |
| May 31, 2026 | 97.41% |
| April 30, 2026 | 97.41% |
| March 31, 2026 | 97.41% |
| February 28, 2026 | 97.41% |
| January 31, 2026 | 97.41% |
| December 31, 2025 | 97.43% |
| November 30, 2025 | 97.48% |
| October 31, 2025 | 97.81% |
| September 30, 2025 | 97.81% |
| August 31, 2025 | 97.81% |
| July 31, 2025 | 97.81% |
| June 30, 2025 | 97.81% |
| May 31, 2025 | 97.81% |
| April 30, 2025 | 97.81% |
| March 31, 2025 | 97.81% |
| February 28, 2025 | 97.81% |
| January 31, 2025 | 97.81% |
| December 31, 2024 | 97.81% |
| November 30, 2024 | 97.81% |
| October 31, 2024 | 98.44% |
| September 30, 2024 | 98.44% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.44% |
| July 31, 2024 | 98.44% |
| June 30, 2024 | 98.44% |
| May 31, 2024 | 98.44% |
| April 30, 2024 | 98.44% |
| March 31, 2024 | 98.44% |
| February 29, 2024 | 98.44% |
| January 31, 2024 | 98.44% |
| December 31, 2023 | 98.44% |
| November 30, 2023 | 98.44% |
| October 31, 2023 | 98.44% |
| September 30, 2023 | 98.44% |
| August 31, 2023 | 98.44% |
| July 31, 2023 | 98.44% |
| June 30, 2023 | 98.44% |
| May 31, 2023 | 98.44% |
| April 30, 2023 | 98.44% |
| March 31, 2023 | 98.44% |
| February 28, 2023 | 98.44% |
| January 31, 2023 | 98.44% |
| December 31, 2022 | 98.44% |
| November 30, 2022 | 98.44% |
| October 31, 2022 | 98.44% |
| September 30, 2022 | 98.44% |
| August 31, 2022 | 98.44% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Gilead Sciences, Inc. | 26.58% |
| Insmed, Inc. | 63.30% |
| United Therapeutics Corp. | 33.00% |
| Vertex Pharmaceuticals, Inc. | 41.60% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 24.38 |
| Beta (5Y) | 0.2020 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 60.61% |
| Historical Sharpe Ratio (5Y) | 0.4356 |
| Historical Sortino (5Y) | 1.122 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 18.29% |